CUSIP 00773J202COM NEWSYREQ4 2025
44 reported transactions
| # | Date | Insider | Title | Type | Shares | Price | Value | Held After | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Jun 3, 2026 | Sloan Sheldon | Chief Medical Officer | M · Option Exercise | 8.3K | $27.46 | $228.8K | 8.3K | SEC |
| 2 | Jun 3, 2026 | Sloan Sheldon | Chief Medical Officer | S · Sell | 8.3K | $75.00 | $625.0K | 0 | SEC |
| 3 | Jun 3, 2026 | Sloan Sheldon | Chief Medical Officer | M · Option Exercise | 8.3K | $0.00 |
See the full Form 4 transaction history for Spyre Therapeutics Inc.
Unlock all transactions| $0 |
| 313.3K |
| SEC |
| 4 | Jun 1, 2026 | Turtle Cameron | Chief Executive Officer | S · Sell | 3.6K | $69.40 | $246.9K | 609.0K | SEC |
| 5 | Jun 1, 2026 | Turtle Cameron | Chief Executive Officer | S · Sell | 8.1K | $70.50 | $574.5K | 600.8K | SEC |
| 6 | Jun 1, 2026 | Turtle Cameron | Chief Executive Officer | S · Sell | 3.3K | $71.38 | $235.1K | 597.5K | SEC |
| 7 | Jun 1, 2026 | Burrows Scott L | Chief Financial Officer | M · Option Exercise | 7.5K | $14.50 | $108.8K | 105.5K | SEC |
| 8 | Jun 1, 2026 | Burrows Scott L | Chief Financial Officer | S · Sell | 1.8K | $69.75 | $125.6K | 103.7K | SEC |
| 9 | Jun 1, 2026 | Burrows Scott L | Chief Financial Officer | S · Sell | 2.6K | $70.77 | $183.9K | 101.1K | SEC |
| 10 | Jun 1, 2026 | Burrows Scott L | Chief Financial Officer | S · Sell | 3.1K | $72.06 | $223.4K | 98.0K | SEC |